Oral pills may prevent the development of: March 2011
Ans. B: Ovarian malignancy Combined oral pills reduce the incidence of functional ovarian cysts (50%) and ovarian and uterine malignancy The incidence of ovarian cancer is reduced by 40% OCP: They are contraceptive agent of choice in: - Newly married - Post aboal - Post paum non-lactating OCP of choice in lactating mother: Minipill They promote development of: Hepatic adenoma Rifampicin reduce their effectiveness Protects against: - Endometrial Ca, - Ovarian Ca - Endometriosis - Rheumatoid ahritis Feility returns back to normal after 6 months of their discontinuation 3rd generation OCPs are lipid friendly
Carcinoma breast
Ovarian malignancy
Submucus fibroid
All of the above